Alembic announces USFDA final approval for Efinaconazole Topical Solution, 10%
Efinaconazole Topical Solution is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Efinaconazole Topical Solution is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Bosentan 32 mg tablets for oral suspension are indicated for the treatment of Pulmonary Arterial Hypertension
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
Subscribe To Our Newsletter & Stay Updated